Camille L. Bedrosian - Global Clinical Development, Alexion Pharmaceuticals, Inc

基本信息

浏览量：53

职业迁徙

个人简介

暂无内容

研究兴趣

论文共 105 篇作者统计合作学者相似作者

按年份排序按引用量排序主题筛选期刊级别筛选合作者筛选合作机构筛选

Immunosuppression to Inhibit Capsid-Specific Humoral Immune Responses in High-Dose AAV Gene Therapy in Cynomolgus Macaques

Deniz Erturk-Hasdemir, Weasel Scott,Alexander Kistner, Leah Cardwell, Justin Serio, Lorraine Sullivan, Ruta Phadnis,Brian E. McIntosh,Camille L. Bedrosian,Emil D. Kakkis,Kathleen McKeever,Samuel C. Wadsworth,Reed Clark,Lorelei Stoica,Barbara A. Sullivan

MOLECULAR THERAPYno. 4 (2023): 568-568

引用0浏览0引用

Response to Triheptanoin Therapy in Critically Ill Patients with LC-FAOD: Report of Patients Treated Through an Expanded Access Program

Jerry Vockley,Gregory M. Enns,Antonio Nino Ramirez,Camille L. Bedrosian,Bridget Reineking,Xiaoxiao Lu,Kathryn Ray,Syeda Rahman,Deborah Marsden

Molecular Genetics and Metabolism（2022）

引用3浏览0WOS引用

Results from a 3-Year Non-interventional, Observational Disease Monitoring Program in Adults with GNE Myopathy

Hanns Lochmueller,Anthony Behin,Ivailo Tournev,Mark Tarnopolsky,Rita Horvath,Oksana Pogoryelova,Jinay Shah,Tony Koutsoukos,Alison Skrinar,Emil Kakkis,Camille L. Bedrosian,Tahseen Mozaffar

Journal of Neuromuscular Diseasesno. 2 (2021): 225-234

引用6浏览0WOS引用

Impact of newborn screening on the reported incidence and clinical outcomes associated with medium- and long-chain fatty acid oxidation disorders

Deborah Marsden,Camille L. Bedrosian,Jerry Vockley

Genetics in medicine : official journal of the American College of Medical Geneticsno. 5 (2021): 816-829

引用28浏览0WOS引用

Clinical Trial Data Available for UX001, Aceneuramic Acid Extended-Release

Camille L. Bedrosian

Journal of the Neurological Sciences（2020）

引用1浏览0WOS引用

Phase I Study of Samalizumab in Chronic Lymphocytic Leukemia and Multiple Myeloma: Blockade of the Immune Checkpoint CD200

Mahadevan Daruka,Lanasa Mark C.,Farber Charles,Pandey Manjari, Whelden Maria,Faas Susan J., Ulery Terrie,Kukreja Anjli, Li Lan,Bedrosian Camille L.,Zhang Xiaoping,Heffner Leonard T.

Journal for ImmunoTherapy of Cancer（2019）

引用55浏览0WOS引用

Eculizumab In Paroxysmal Nocturnal Haemoglobinuria And Atypical Haemolytic Uraemic Syndrome: 10-Year Pharmacovigilance Analysis

Gerard Socie,Marie-Pierre Caby-Tosi,Jing L. Marantz,Alexander Cole,Camille L. Bedrosian,Christoph Gasteyger,Arshad Mujeebuddin,Peter Hillmen,Johan Vande Walle,Hermann Haller

BRITISH JOURNAL OF HAEMATOLOGY（2019）

引用146浏览0WOS引用

146

Interim Analysis of Safety Outcomes During Treatment with Eculizumab: Results from the International Paroxysmal Nocturnal Hemoglobinuria Registry

Anita Hill,Alexander Roeth,Gerard Socie,Marie-Pierre Caby-Tosi,Amanda Wilson,Philippe Gustovic,Camille L. Bedrosian,Robert A. Brodsky

Blood（2017）

引用24浏览0引用

Eculizumab is a Safe and Effective Treatment in Pediatric Patients with Atypical Hemolytic Uremic Syndrome

Larry A. Greenbaum,Marc Fila,Gianluigi Ardissino,Samhar I. Al-Akash,Jonathan Evans,Paul Henning,Kenneth V. Lieberman,Silvio Maringhini,Lars Pape,Lesley Rees,Nicole C. A. J. van de Kar,Johan Vande Walle,Masayo Ogawa,Camille L. Bedrosian,Christoph Licht

Kidney international（2016）

引用221浏览0WOS引用

221

Assessment of Human Antihuman Antibodies to Eculizumab After Long‐Term Treatment in Patients With Paroxysmal Nocturnal Hemoglobinuria

Peter Hillmen,P Muus,Jeffrey Szer,Anita Hill,Britta Hochsmann,Austin G Kulasekararaj,Antonio M Risitano,Eric Van Den Neste,Maria Liljeholm, Kurt S Ebrahim,Camille L Bedrosian,Xiang Gao, Donna Ames,Gerard Socie

AMERICAN JOURNAL OF HEMATOLOGY（2016）

引用13浏览0WOS引用

加载更多

作者统计

合作学者

合作机构

D-Core

合作者
学生
导师

暂无相似学者，你可以通过学者研究领域进行搜索筛选

数据免责声明

页面数据均来自互联网公开来源、合作出版商和通过AI技术自动分析结果，我们不对页面数据的有效性、准确性、正确性、可靠性、完整性和及时性做出任何承诺和保证。若有疑问，可以通过电子邮件方式联系我们：report@aminer.cn